{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:16:04Z","timestamp":1790662564083,"version":"4.1.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pnpbp.2026.111640","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:55:59Z","timestamp":1770684959000},"page":"111640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Alzheimer's disease: Current therapeutic strategies and emerging perspectives for multifactorial intervention"],"prefix":"10.1016","volume":"145","author":[{"given":"J\u00falia Gabriela","family":"de Melo Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellinghton","family":"de Medeiros Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathasha Maria Correa Prado","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Maria Quaglio","family":"Bellozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111640_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108024","article-title":"Rational design, synthesis and computational studies of multi-targeted anti-Alzheimer\u2019s agents integrating coumarin scaffold","volume":"154","author":"Abd El-Mageed","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012759","article-title":"Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series","volume":"7","author":"Abraha","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0015","series-title":"Anvisa","article-title":"Kisunla (donanemabe): novo registro","author":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria","year":"2025"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ceca.2009.12.010","article-title":"Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors","volume":"47","author":"Alberdi","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174178","article-title":"siRNA: mechanism of action, challenges, and therapeutic approaches","volume":"905","author":"Alshaer","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0035","author":"Alzheimer Europe"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0040","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer\u2019s disease facts and figures","volume":"19","author":"Alzheimer\u2019\u2019s Association","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111640_bb0030","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"Alzheimer\u2019s Association 2024 Alzheimer\u2019s Disease Facts and Figures","volume":"20","year":"2024","journal-title":"Alzheimers Dementi"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0045","author":"Alzheimer'\u2019s Drug Discovery Foundation"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0050","author":"American Art Therapy Association"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140436","article-title":"Discovery of pyrazoline analogs as multi-targeting cholinesterase, \u03b2-secretase and A\u03b2 aggregation inhibitors through lead optimization strategy","volume":"301","author":"Bajad","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.18071\/isz.74.0379","article-title":"Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias","volume":"74","author":"Bal\u00e1zs","year":"2021","journal-title":"Ideggyogy. Sz."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0070","first-page":"1","article-title":"Autosomal-dominant Alzheimer\u2019s disease: a review and proposal for the prevention of Alzheimer\u2019s disease","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/acsptsci.1c00200","article-title":"In silico and ex vivo analyses of the inhibitory action of the Alzheimer drug Posiphen and primary metabolites with human acetyl- and Butyrylcholinesterase enzymes","volume":"5","author":"Batool","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0080","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.3390\/molecules27248823","article-title":"BACE1 inhibitors for Alzheimer\u2019s disease: the past, present and any future?","volume":"27","author":"Bazzari","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbr.2019.02.030","article-title":"Voluntary, involuntary and forced exercises almost equally reverse behavioral impairment by regulating hippocampal neurotrophic factors and oxidative stress in experimental Alzheimer\u2019s disease model","volume":"364","author":"Belviranl\u0131","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149018","article-title":"Immunotherapeutic approaches for Alzheimer\u2019s disease: exploring active and passive vaccine progress","volume":"1840","author":"Bhadane","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0095","author":"Biogen"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0753-3322(89)90109-1","article-title":"Alzheimer\u2019s disease and THA: a review of the cholinergic theory and of preliminary results","volume":"43","author":"Boller","year":"1989","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0105","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of Aducanumab in early Alzheimer\u2019s disease","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1037\/bul0000325","article-title":"Effectiveness of cognitive stimulation for dementia: a systematic review and meta-analysis","volume":"147","author":"Cafferata","year":"2021","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0120","series-title":"Dem\u00eancias do tipo n\u00e3o Alzheimer [recurso eletr\u00f4nico]: dem\u00eancias focais frontotemporais","author":"Caixeta","year":"2010"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0125","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.3390\/jcm11195752","article-title":"Effects of reminiscence therapy on cognition, depression and quality of life in elderly people with Alzheimer\u2019s disease: a systematic review of randomized controlled trials","volume":"11","author":"Cammisuli","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0130","series-title":"FDA\u2019s Decision to Approve New Treatment for Alzheimer\u2019s Disease [WWW Document]","author":"Cavazzoni","year":"2021"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101462","article-title":"Modeling sporadic Alzheimer\u2019s disease in human brain organoids under serum exposure","volume":"8","author":"Chen","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0145","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3390\/ijms22052283","article-title":"Involvement of cholinergic, adrenergic, and glutamatergic network modulation with cognitive dysfunction in Alzheimer\u2019s disease","volume":"22","author":"Cheng","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0150","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/emboj.2013.146","article-title":"Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles","volume":"32","author":"Cheret","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0155","author":"ClinicalTrials - NIH"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1101452","article-title":"Advances in Alzheimer\u2019s disease\u2019s pharmacological treatment","volume":"14","author":"Conti Filho","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0165","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/ijms19040956","article-title":"Neuroimmune tau mechanisms: their role in the progression of neuronal degeneration","volume":"19","author":"Cort\u00e9s","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0170","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment combinations for Alzheimer\u2019s disease: current and future pharmacotherapy options","volume":"67","author":"Cummings","year":"2019","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0175","author":"da Sa\u00fade"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70456","article-title":"Investigating the oxidative stress\u2013vascular brain injury axis in mild cognitive impairment of the Alzheimer\u2019s type","volume":"21","author":"Detcheverry","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0185","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s40520-021-01837-8","article-title":"Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer\u2019s disease","volume":"33","author":"Devita","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0190","series-title":"Donepezil [WWW Document]","author":"DRUGBANK","year":"2024"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0200","series-title":"FDA Approves Updated Label for Lilly\u2019s Kisunla (donanemab-azbt) with New Dosing in Early Symptomatic Alzheimer\u2019s Disease","author":"Eli Lilly and Company","year":"2025"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14283\/jpad.2022.84","article-title":"Buntanetap, a novel translational inhibitor of multiple neurotoxic proteins, proves to be safe and promising in both Alzheimer\u2019s and Parkinson\u2019s patients","volume":"10","author":"Fang","year":"2023","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-015-0108-3","article-title":"Long-term treatment with active a\u03b2 immunotherapy with CAD106 in mild Alzheimer\u2019s disease","volume":"7","author":"Farlow","year":"2015","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0215","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/brain\/awad024","article-title":"Tilavonemab in early Alzheimer\u2019s disease: results from a phase 2, randomized, double-blind study","volume":"146","author":"Florian","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer disease: the amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0230","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.tins.2023.07.006","article-title":"Alzheimer\u2019s disease and related tauopathies: disorders of disrupted neuronal identity","volume":"46","author":"Frost","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0235","series-title":"Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer\u2019s disease: a meta-analysis","author":"Glinz","year":"2019"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0240","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.3390\/ijerph18158067","article-title":"Comparative efficacy of active group music intervention versus group music listening in Alzheimer\u2019s disease","volume":"18","author":"G\u00f3mez-Gallego","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0245","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1177\/07334648221089283","article-title":"Cognitive stimulation in moderate Alzheimer\u2019s disease","volume":"41","author":"Gonzalez-Moreno","year":"2022","journal-title":"J. Appl. Gerontol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0250","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/cpt.2875","article-title":"Donanemab population pharmacokinetics, amyloid plaque reduction, and safety in participants with Alzheimer\u2019s disease","volume":"113","author":"Gueorguieva","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1831","article-title":"Memantine, donepezil, or combination therapy\u2014what is the best therapy for Alzheimer\u2019s disease? A network meta-analysis","volume":"10","author":"Guo","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0260","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The \u03b2-secretase BACE1 in Alzheimer\u2019s disease","volume":"89","author":"Hampel","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0265","doi-asserted-by":"crossref","first-page":"29747","DOI":"10.1038\/s41598-024-75448-4","article-title":"Light-based gamma entrainment with novel invisible spectral flicker stimuli","volume":"14","author":"Hansen","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0270","first-page":"184","article-title":"Alzheimer\u2019s disease: the amyloid Cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science (1979)"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0275","series-title":"Risk Reduction of Cognitive Decline and Dementia:Who Guideline. Geneva","author":"Health Organization, W","year":"2019"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0280","series-title":"Global Status Report on the Public Health Response to Dementia, Geneva","author":"Health Organization, W","year":"2021"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/7834421","article-title":"Mesenchymal stem cell therapy for Alzheimer\u2019s disease","volume":"2021","author":"Hern\u00e1ndez","year":"2021","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70131","article-title":"Multi-target drug design in Alzheimer\u2019s disease treatment: emerging technologies, advantages, challenges, and limitations","volume":"13","author":"Hossain","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.686005","article-title":"Art therapy: a complementary treatment for mental disorders","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0300","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.brs.2019.06.003","article-title":"Effects of 6-month at-home transcranial direct current stimulation on cognition and cerebral glucose metabolism in Alzheimer\u2019s disease","volume":"12","author":"Im","year":"2019","journal-title":"Brain Stimul."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0305","series-title":"AC Immune Advances phospho-Tau Alzheimer\u2019s Vaccine in Phase 1b\/2a Study","author":"Immune","year":"2020"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0310","series-title":"AC Immune\u2019s Alzheimer\u2019s Vaccine Generates Potent Anti-pTau Antibody Response in a Phase 1b\/2a Study","author":"Immune","year":"2021"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0315","series-title":"AC Immune\u2019s Targeted Anti-pTau Active Immunotherapy for Alzheimer\u2019s Disease Advances into Phase 2b Trial","author":"Immune","year":"2023"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0320","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3233\/JAD-180164","article-title":"Effects of meditation and music-listening on blood biomarkers of cellular aging and Alzheimer\u2019s disease in adults with subjective cognitive decline: an exploratory randomized clinical trial","volume":"66","author":"Innes","year":"2018","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0325","series-title":"Understanding Alzheimer\u2019s Disease: What You Need To Know","author":"Institute on Aging","year":"2023"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis","author":"Karch","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0335","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/1545968319840285","article-title":"Therapeutic role of transcranial direct current stimulation in Alzheimer disease patients: double-blind, placebo-controlled clinical trial","volume":"33","author":"Khedr","year":"2019","journal-title":"Neurorehabil. Neural Repair"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1399121","article-title":"Alzheimer\u2019s disease and its treatment\u2013yesterday, today, and tomorrow","volume":"15","author":"Kim","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0345","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1111\/bph.14030","article-title":"Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer\u2019s disease","volume":"174","author":"Kim","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0350","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1017\/S1461145714000613","article-title":"Galantamine promotes adult hippocampal neurogenesis via M1 muscarinic and \u03b17 nicotinic receptors in mice","volume":"17","author":"Kita","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0355","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12888-019-2245-x","article-title":"Effectiveness of the dog therapy for patients with dementia - a systematic review","volume":"19","author":"Klimova","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0360","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuroimage.2017.12.048","article-title":"Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer\u2019s disease","volume":"169","author":"Koch","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0365","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41386-021-01137-9","article-title":"Development of prefrontal cortex","volume":"47","author":"Kolk","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0370","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13195-024-01620-7","article-title":"Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer\u2019s disease, positive for plasma p-tau217","volume":"16","author":"Kovacech","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0375","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13312-020-1736-7","article-title":"Antisense oligonucleotides: a unique treatment approach","volume":"57","author":"Krishnan","year":"2020","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0380","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13195-018-0340-8","article-title":"Safety, tolerability and immunogenicity of an active anti-A\u03b240 vaccine (ABvac40) in patients with Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase I trial","volume":"10","author":"Lacosta","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0385","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/pcn.13504","article-title":"Endogenous antioxidants predicted outcome and increased after treatment: a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer\u2019s disease","volume":"77","author":"Lane","year":"2023","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.614351","article-title":"Repetitive transcranial magnetic stimulation with H-coil in Alzheimer\u2019s disease: a double-blind, placebo-controlled pilot study","volume":"11","author":"Leocani","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0395","article-title":"Effects of sodium benzoate on cognitive function in neuropsychiatric disorders: a systematic review and meta-analysis","volume":"15","author":"Liang","year":"2024","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0400","article-title":"Galantamine for dementia due to Alzheimer\u2019s disease and mild cognitive impairment","volume":"2024","author":"Lim","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0405","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41398-025-03492-3","article-title":"Sodium benzoate treatment decreased amyloid beta peptides and improved cognitive function among patients with Alzheimer\u2019s disease: secondary analysis of a randomized clinical trial","volume":"15","author":"Lin","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0410","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/ijnp\/pyad061","article-title":"Elucidating the mechanisms of sodium benzoate in Alzheimer disease: insights from quantitative proteomics analysis of serum samples","volume":"26","author":"Lin","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0415","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the lancet standing commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0420","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/1039856218766123","article-title":"Alzheimer disease: non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms","volume":"26","author":"Loi","year":"2018","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0425","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3390\/ijms22062897","article-title":"Physical exercise and Alzheimer\u2019s disease: effects on pathophysiological molecular pathways of the disease","volume":"22","author":"L\u00f3pez-Ortiz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100016","article-title":"Blarcamesine for the treatment of early Alzheimer\u2019s disease: results from the ANAVEX2-73-AD-004 phase IIB\/III trial","volume":"12","author":"Macfarlane","year":"2025","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0435","doi-asserted-by":"crossref","DOI":"10.1080\/1028415X.2024.2415867","article-title":"Safety and efficacy of sodium benzoate for patients with mild Alzheimer\u2019s disease: a systematic review and meta-analysis","author":"Mansour","year":"2025","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0445","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.regg.2015.10.006","article-title":"Eficacia de la terapia ocupacional y otras terapias no farmacol\u00f3gicas en el deterioro cognitivo y la enfermedad de Alzheimer","volume":"51","author":"Matilla-Mora","year":"2016","journal-title":"Rev. Esp. Geriatr. Gerontol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0450","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu115","article-title":"Combination therapy with cholinesterase inhibitors and Memantine for Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"18","author":"Matsunaga","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0455","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13195-022-01124-2","article-title":"Lecanemab in patients with early Alzheimer\u2019s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study","volume":"14","author":"McDade","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0460","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003154.pub6","article-title":"Memantine for dementia","author":"McShane","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0465","series-title":"Protocolo Cl\u00ednico e Diretizes Terap\u00eauticas da Doen\u00e7a de Alzheimer","author":"Minist\u00e9rio da sa\u00fade","year":"2017"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0470","series-title":"Update Phase 2 Study of ABVAC40, An Active Vaccine ANTI-A\u039240 In Patients With Mild Cognitive Impairment Or Very-Mild Alzheimer\u2019s Disease Objectives Top Line Data (Part A)","author":"Molina","year":"2022"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0475","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207663","article-title":"Randomized phase II study of the safety and efficacy of Semorinemab in participants with mild-to-moderate Alzheimer disease: Lauriet","volume":"101","author":"Monteiro","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0480","author":"National Center for Biotechnology Information"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0485","doi-asserted-by":"crossref","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in alzheimer disease: a complex but coherent relationship","author":"Nelson","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0490","series-title":"Dementia: assessment, management and support for people living with dementia and their carers","author":"NICE","year":"2018"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0495","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13195-018-0436-1","article-title":"FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer\u2019s disease","volume":"10","author":"Novak","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0500","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/jgs.14059","article-title":"Effects of exercise on cognition: the Finnish Alzheimer disease exercise trial: a randomized, controlled trial","volume":"64","author":"\u00d6hman","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0510","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.gerinurse.2016.04.002","article-title":"Effect of animal-assisted activity on balance and quality of life in home-dwelling persons with dementia","volume":"37","author":"Olsen","year":"2016","journal-title":"Geriatr. Nurs. (Minneap)."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0515","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/pharmaceutics16010121","article-title":"Design and synthesis of multi-functional ligands through Hantzsch reaction: targeting Ca2+ channels, activating Nrf2 and possessing Cathepsin S inhibitory, and antioxidant properties","volume":"16","author":"Pach\u00f3n-Angona","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1243869","article-title":"Exercise therapy to prevent and treat Alzheimer\u2019s disease","volume":"15","author":"Pahlavani","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0525","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/pharmaceutics14061117","article-title":"Therapeutic approach to Alzheimer\u2019s disease: current treatments and new perspectives","volume":"14","author":"Pardo-Moreno","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0530","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.neuron.2024.05.008","article-title":"Principles of cortical areas and their implications for neuroimaging","volume":"112","author":"Petersen","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0535","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2741\/E605","article-title":"Genetics of familial and sporadic Alzheimer\u2019s disease","volume":"5","author":"Piaceri","year":"2013","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0540","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/ijms24010778","article-title":"Apoe4 and Alzheimer\u2019s disease pathogenesis\u2014mitochondrial deregulation and targeted therapeutic strategies","volume":"24","author":"Pires","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0545","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/healthcare9060698","article-title":"Impact of Alzheimer\u2019s dementia on caregivers and quality improvement through art and music therapy","volume":"9","author":"Popa","year":"2021","journal-title":"Healthcare"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0550","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.freeradbiomed.2016.01.024","article-title":"Physical exercise, reactive oxygen species and neuroprotection","volume":"98","author":"Radak","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0555","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","article-title":"Hippocampus and its involvement in Alzheimer\u2019s disease: a review","volume":"12","author":"Rao","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0560","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41398-020-0709-x","article-title":"Rivastigmine modifies the \u03b1-secretase pathway and potentially early Alzheimer\u2019s disease","volume":"10","author":"Ray","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0565","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1515\/revneuro-2017-0063","article-title":"Amyloid toxicity in Alzheimer\u2019s disease","volume":"29","author":"Reiss","year":"2018","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0570","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.3390\/ijms23063245","article-title":"Physical exercise, a potential non-pharmacological intervention for attenuating Neuroinflammation and cognitive decline in Alzheimer\u2019s disease patients","volume":"23","author":"Ribari\u010d","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0575","first-page":"17","article-title":"La stimulation cognitive. NPG Neurologie - Psychiatrie - G\u00e9riatrie","volume":"6","author":"Rotrou","year":"2006"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0580","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/ADR-210299","article-title":"A new hypothesis for Alzheimer\u2019s disease: the lipid invasion model","volume":"6","author":"Rudge","year":"2022","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117720","article-title":"Probing new 3-hydrazinyl indole phenacetamide derivatives as multitarget anti-Alzheimer: synthesis, in vivo, in vitro, and in silico studies","volume":"295","author":"Said","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0590","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","article-title":"Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating Aducanumab in patients with early Alzheimer disease","volume":"79","author":"Salloway","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0595","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/geront\/gnt100","article-title":"Cognitive, emotional, and social benefits of regular musical activities in early dementia: randomized controlled study","volume":"54","author":"S\u00e4rk\u00e4m\u00f6","year":"2014","journal-title":"Gerontologist"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0600","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0605","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2019.10374","article-title":"Cholinesterase inhibitors as Alzheimer\u2019s therapeutics (Review)","author":"Sharma","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0610","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s43587-023-00523-w","article-title":"TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer\u2019s disease","volume":"3","author":"Shulman","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2022.100120","article-title":"Comparative study of rivastigmine and galantamine on the transgenic drosophila model of Alzheimer\u2019s disease","volume":"3","author":"Siddique","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0620","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.3390\/molecules30092048","article-title":"Nrf2 activation and antioxidant properties of Chromone-containing MTDLs for Alzheimer\u2019s disease treatment","volume":"30","author":"Simakov","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0625","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0630","doi-asserted-by":"crossref","DOI":"10.5014\/ajot.2024.078101","article-title":"Occupational therapy practice guidelines for adults living with Alzheimer\u2019s disease and related neurocognitive disorders","volume":"78","author":"Smallfield","year":"2024","journal-title":"Am. J. Occup. Ther."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0635","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","article-title":"Immunotherapy for Alzheimer\u2019s disease: targeting \u03b2-amyloid and beyond","volume":"11","author":"Song","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0640","series-title":"Doen\u00e7a de Alzheimer: Diagn\u00f3stico e Tratamento. Manole, Santana de Parna\u00edba","first-page":"166","article-title":"Tratamento farmacol\u00f3gico da cogni\u00e7\u00e3o","author":"Sousa","year":"2024"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113984","article-title":"Intermittent theta burst stimulation ameliorates cognitive impairment and hippocampal gliosis in the Streptozotocin-induced model of Alzheimer\u2019s disease","volume":"433","author":"Stanojevic","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0650","author":"Strobel"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0655","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1254\/jjp.89.7","article-title":"Research and Development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor","volume":"89","author":"Sugimoto","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0660","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/pn-2023-003746","article-title":"Clinical assessment of parietal lobe function","volume":"23","author":"Tabi","year":"2023","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0665","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180138","article-title":"Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models","author":"Taoufik","year":"2018","journal-title":"Open Biol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0670","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamaneurol.2022.1375","article-title":"Safety and efficacy of Semorinemab in individuals with prodromal to mild Alzheimer disease","volume":"79","author":"Teng","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101499","article-title":"Efficacy of non-invasive brain stimulation on global cognition and neuropsychiatric symptoms in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis and systematic review","volume":"72","author":"Teselink","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072301","article-title":"Efficacy and safety of a liposome-based vaccine against protein tau, assessed in tau.P301L mice that model Tauopathy","volume":"8","author":"Theunis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0685","first-page":"506","article-title":"Impact of animal-assisted therapy on well-being in patients with Alzheimer\u2019s disease (ELIAUT study)","volume":"21","author":"Thirion","year":"2023","journal-title":"Geriatr. Psychol. Neuropsychiatr. Vieil."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0690","series-title":"Glutamate Transmission and Toxicity In Alzheimer\u2019s Disease, & Biol. Psychiat","author":"Timothy Greenamyre","year":"1988"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0695","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/BrImp.2017.6","article-title":"Testing the benefits of cognitive training vs. cognitive stimulation in mild Alzheimer\u2019s disease: a randomised controlled trial","volume":"18","author":"Tsantali","year":"2017","journal-title":"Brain Impairment"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0700","doi-asserted-by":"crossref","first-page":"863.e1","DOI":"10.1016\/j.jamda.2016.05.015","article-title":"Combination therapy showed limited superiority over monotherapy for Alzheimer disease: a meta-analysis of 14 randomized trials","volume":"17","author":"Tsoi","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0705","doi-asserted-by":"crossref","first-page":"566","DOI":"10.25259\/JNRP_356_2023","article-title":"Guidelines for pharmacotherapy in Alzheimer\u2019s disease \u2013 a primer on FDA-approved drugs","volume":"14","author":"Varadharajan","year":"2023","journal-title":"J. Neurosci. Rural Pract."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173554","article-title":"Alzheimer\u2019s disease: recent treatment strategies","volume":"887","author":"Vaz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0715","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/156720509787602852","article-title":"Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders","volume":"6","author":"Vellas","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0720","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ptr.8369","article-title":"Identification of Cannabidiolic and Cannabigerolic Acids as <scp>MTDL AChE<\/scp>, <scp>BuChE,<\/scp> and <scp>BACE<\/scp> \u22121 Inhibitors Against Alzheimer\u2019s Disease by In Silico, In Vitro, and In Vivo Studies","volume":"39","author":"Vitale","year":"2025","journal-title":"Phytother. Res."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0725","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1471-6712.2011.00895.x","article-title":"A community-based exercise programme to improve functional ability in people with Alzheimer\u2019s disease: a randomized controlled trial","volume":"26","author":"Vreugdenhil","year":"2012","journal-title":"Scand. J. Caring Sci."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0730","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12967-022-03464-x","article-title":"Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"20","author":"Wabik","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0735","first-page":"262","article-title":"UB-311, a novel UBITh \u00ae amyloid \u03b2 peptide vaccine for mild Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2017","journal-title":"Alzheimer\u2019s & Dementia: Transl. Res. Clin. Intervent."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2020.103706","article-title":"Effects and mediating mechanisms of a structured limbs-exercise program on general cognitive function in older adults with mild cognitive impairment: a randomized controlled trial","volume":"110","author":"Wang","year":"2020","journal-title":"Int. J. Nurs. Stud."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0745","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0750","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamaneurol.2019.3988","article-title":"Efficacy and safety of Lanabecestat for treatment of early and mild Alzheimer disease","volume":"77","author":"Wessels","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0755","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brs.2021.11.007","article-title":"Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer\u2019s disease: a randomized controlled trial","volume":"15","author":"Wu","year":"2022","journal-title":"Brain Stimul."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0760","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.exger.2015.10.015","article-title":"Galantamine attenuates amyloid-\u03b2 deposition and astrocyte activation in APP\/PS1 transgenic mice","volume":"72","author":"Wu","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0765","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s43856-024-00527-6","article-title":"Combined use of donepezil and Memantine increases the probability of five-year survival of Alzheimer\u2019s disease patients","volume":"4","author":"Yaghmaei","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0770","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mam.2011.10.005","article-title":"Shift in brain metabolism in late onset Alzheimer\u2019s disease: implications for biomarkers and therapeutic interventions","volume":"32","author":"Yao","year":"2011","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0775","doi-asserted-by":"crossref","DOI":"10.2147\/CIA.S159920","article-title":"Clinical Efficacy and Safety of Donepezil in the Treatment of Alzheimer\u2019s Disease in Chinese Patients","author":"Zhang","year":"2018","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0780","doi-asserted-by":"crossref","first-page":"33864","DOI":"10.18632\/oncotarget.13060","article-title":"Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer\u2019s disease patients","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0785","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1111\/jgs.18025","article-title":"Effectiveness and safety of anti-tau drugs for Alzheimer\u2019s disease: systematic review and meta-analysis","volume":"70","author":"Zheng","year":"2022","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0790","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.7150\/thno.46436","article-title":"Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics","volume":"11","author":"Zhu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.01058","article-title":"The multidisciplinary approach to Alzheimer\u2019s disease and dementia. A narrative review of non-pharmacological treatment","volume":"9","author":"Zucchella","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111640_bb0220","series-title":"FDA Approves Treatment for Adults with Alzheimer\u2019s Disease [WWW Document]","year":"2024"},{"key":"10.1016\/j.pnpbp.2026.111640_bb0505","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jshs.2020.01.004","article-title":"Physical exercise in the prevention and treatment of Alzheimer\u2019s disease","volume":"9","author":"De la Rosa","year":"2020","journal-title":"J. Sport Health Sci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:31:18Z","timestamp":1776493878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":159,"alternative-id":["S0278584626000369"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111640","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer's disease: Current therapeutic strategies and emerging perspectives for multifactorial intervention","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111640"}}